Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Blood (2024) 144 (Supplement 1): 2187.

https://doi.org/10.1182/blood-2024-206919

Published: 2024

Journal Articles

Molecular Measurable Residual Disease before Transplantation Independently Predicts Survival and Relapse Risk in Adult KMT2A-Rearranged Acute Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 2938.

https://doi.org/10.1182/blood-2024-204843

Published: 2024

Journal Articles

Machine Learning Algorithm As a Prognostic Tool for Epstein-Barr Virus Reactivation after Haploidentical Hematopoietic Stem Cell Transplantation

Shuang Fan, Hao-Yang Hong, Xin-Yu Dong, Lan-Ping Xu, Xiao-hui Zhang, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Fengrong Wang, Jing-Zhi Wang, Kaiyan Liu, Meng-Zhu Shen, Xiao-jun Huang, Shen-Da Hong, Xiao-Dong Mo

Blood (2022) 140 (Supplement 1): 7691–7692.

https://doi.org/10.1182/blood-2022-165067

Published: 2022

Journal Articles

Efficacy and Safety of MSCs Plus Basiliximab for the Treatment of Steroid-Resistant aGVHD after Haploidentical Stem Cell Transplantation: A Multicenter, Randomized, Open-Label Trial

Blood (2022) 140 (Supplement 1): 4770–4771.

https://doi.org/10.1182/blood-2022-166307

Published: 2022

Journal Articles

Thrombopoietin Levels Predict the Response to Avatrombopag Treatment in Patients with Persistent Thrombocytopenia after Haploidentical Hematopoietic Stem Cell Transplantation

Haixia Fu, Meng Lv, Yuanyuan Zhang, Tingting Han, Xiao-Dong Mo, Fengrong Wang, Chenhua Yan, Jun Kong, Yu Wang, Yuqian Sun, Wei Han, Huan Chen, Yao Chen, Yu-Hong Chen, Lanping Xu, Kaiyan Liu, Xiaojun Huang, Xiaohui Zhang

Blood (2022) 140 (Supplement 1): 4705–4706.

https://doi.org/10.1182/blood-2022-166920

Published: 2022

Journal Articles

Real-World Study of the Use of Iguratimod to Treat Chronic/Refractory ITP

Blood (2022) 140 (Supplement 1): 5567–5568.

https://doi.org/10.1182/blood-2022-167362

Published: 2022

Journal Articles

An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study

Si-Qi Li, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Huan Chen, Yu-Hong Chen, Feng-Rong Wang, Wei Han, Yu-Qian Sun, Chen-Hua Yan, Meng Lv, Fei-Fei Tang, Xiao-Dong Mo, Yan-Rong Liu, Kai-Yan Liu, Ying-Jun Chang, Xiao-Jun Huang

Blood (2022) 140 (5): 516–520.

https://doi.org/10.1182/blood.2021014604

Published: 2022

Includes: Supplemental data

Journal Articles

Treatment Outcome and Efficacy of Therapeutic Plasma Exchange for Transplant-Associated Thrombotic Microangiopathy in a Real-World Large Cohort Study

Li-Ping Yang, Peng Zhao, Ye-Jun Wu, Hai-Xia Fu, Yun He, Xiao-Dong Mo, Meng Lv, Feng-Rong Wang, Chen-Hua Yan, Yu-Hong Chen, Ying-Jun Chang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang, Xiao-Hui Zhang

Blood (2021) 138 (Supplement 1): 1013.

https://doi.org/10.1182/blood-2021-149373

Published: 2021

Journal Articles

Tacrolimus Plus High-Dose Dexamethasone Versus High-Dose Dexamethasone Alone As First-Line Treatment for Adult Immune Thrombocytopenia: The Phase 2, Open Label, Randomized Trial (TARGET 020)

Blood (2021) 138 (Supplement 1): 13.

https://doi.org/10.1182/blood-2021-152111

Published: 2021

Journal Articles

Superiority of Leukemic Stem Cell-Based Minimal Residual Disease Assay to Traditional Multiparameter Flow Cytometry-Based Method for Relapse Prediction in AML Patients: A Prospective Study with Randomized Training and Validation Sets

Siqi Li, Lan-Ping Xu, Yu Wang, Xiaohui Zhang, Huan Chen, Yu-Hong Chen, Fengrong Wang, Wei Han, Yuqian Sun, Chenhua Yan, Meng Lyu, Feifei Tang, Xiao-Dong Mo, Kai-Yan Liu, Yingjun Chang, Xiao Jun Huang

Blood (2021) 138 (Supplement 1): 517.

https://doi.org/10.1182/blood-2021-150011

Published: 2021

Journal Articles

Machine-Learning Based Early Warning System for Prediction for Disseminated Intravascular Coagulation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Multicenter Study

Blood (2021) 138 (Supplement 1): 2113.

https://doi.org/10.1182/blood-2021-150437

Published: 2021

Journal Articles

M1 and M2 Macrophages Play Different Roles in the Pathogenesis of Acute Graft-Versus-Host Disease Post-Allotransplant By Modulating Immune Microenvironment

Qi Wen, MD, Hong-Yan Zhao, PhD, Zhong-Shi Lyu, Yao Weili, Ting-Ting Han, Yu-Hong Chen, Yu Wang, Lan-Ping Xu, Xiao-Hui Zhang, Yuan Kong, Xiao-Jun Huang

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-136021

Published: 2020

Journal Articles

Development and Validation of a Prognostic Model for Transplant-Associated Thrombotic Microangiopathy Following Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-138408

Published: 2020

Journal Articles

Haploidentical Hematopoietic Stem Cell Transplantation May Improve Prognosis in Non-Infant Children with t(v;11q23)/MLL-Rearranged B-Acute Lymphoblastic Leukemia

Blood (2019) 134 (Supplement_1): 2049.

https://doi.org/10.1182/blood-2019-127704

Published: 2019

Journal Articles

Regulation of the Elevated T Cell Glycolysis May Alleviate Acute Graft-Versus-Host Disease Post-Allotransplant

Qi Wen, MD, Song Yang, Zhong-Shi Lyu, PhD, Wei-Li Yao, Yu-Hong Chen, Ting-Ting Han, Yu Wang, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang, Yuan Kong, MD PhD

Blood (2019) 134 (Supplement_1): 600.

https://doi.org/10.1182/blood-2019-122795

Published: 2019

Journal Articles

Autophagy in Endothelial Cells Regulates Their Hematopoiesis Supporting Ability

Yuan Kong, MD PhD, Xie-Na Cao, Zhong-Shi Lyu, PhD, Xiao-Dong Mo, Qi Wen, MD, Hong-Yan Zhao, MD, Yu-Hong Chen, Yu Wang, Ying-Jun Chang, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang

Blood (2019) 134 (Supplement_1): 4425.

https://doi.org/10.1182/blood-2019-122227

Published: 2019

Journal Articles

Rituximab for Desensitization during HLA-Mismatched Stem Cell Transplantation in Patients with a Positive Donor Specific Anti-HLA Antibody: A Prospective Study

Ying-Jun Chang, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Huan Chen, Yu-Hong Chen, Feng-Rong Wang, Wei Han, Yu-Qian Sun, Chenhua Yan, Fei-Fei Tang, Ming-Rui Huo, Xiao-Dong Mo, MD, Xiang-Yu Zhao, Kai-yan Liu, Xiao-Jun Huang

Blood (2019) 134 (Supplement_1): 5622.

https://doi.org/10.1182/blood-2019-129781

Published: 2019

Journal Articles

Comparable Outcomes after Hematopoietic Stem Cell Transplantation from Mother Donors and Matched Unrelated Donors in Patients with Hematopoietic Malignancies

Rui MA, Xiao-Jun Huang, Lan-Ping Xu, Kaiyan Liu, Xiaohui Zhang, MD, Chen-Hua Yan, Wei Han, Feng-Rong Wang, Yu-Hong Chen, Huan Chen, Yao Chen, MD, Jing-Zhi Wang, Yu Wang

Blood (2018) 132 (Supplement 1): 3463.

https://doi.org/10.1182/blood-2018-99-113961

Published: 2018

Journal Articles

Positive Stool Cultures Could Predict the Clinical Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation

Lijuan Hu, Qi Wang, PhD, Xiaohui Zhang, Lan-Ping Xu, MD, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Kaiyan Liu, MD PhD, Hui Wang, PhD, Xiaojun Huang, MD, Xiao-Dong Mo

Blood (2018) 132 (Supplement 1): 5757.

https://doi.org/10.1182/blood-2018-99-109858

Published: 2018

Journal Articles

Hepatitis E Virus Infection after Haploidentical Hematopoietic Stem Cell Transplantation:Incidence and Clinical Course

Fei-Fei Tang, Xiao-Dong Mo, Yu Wang, Chen-Hua Yan, Yu-Hong Chen, Huan Chen, Wei Han, Ying-Jun Chang, Hai-Ying Zhang, Yan-Di Xie, Hui Ma, Lai Wei, Lan-Ping Xu, Xiao-Jun Huang, Xiaohui Zhang, MD

Blood (2018) 132 (Supplement 1): 5734.

https://doi.org/10.1182/blood-2018-99-113953

Published: 2018

NARROW

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Molecular Measurable Residual Disease before Transplantation Independently Predicts Survival and Relapse Risk in Adult KMT2A-Rearranged Acute Myeloid Leukemia

Machine Learning Algorithm As a Prognostic Tool for Epstein-Barr Virus Reactivation after Haploidentical Hematopoietic Stem Cell Transplantation

Efficacy and Safety of MSCs Plus Basiliximab for the Treatment of Steroid-Resistant aGVHD after Haploidentical Stem Cell Transplantation: A Multicenter, Randomized, Open-Label Trial

Thrombopoietin Levels Predict the Response to Avatrombopag Treatment in Patients with Persistent Thrombocytopenia after Haploidentical Hematopoietic Stem Cell Transplantation

Real-World Study of the Use of Iguratimod to Treat Chronic/Refractory ITP

An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study

Treatment Outcome and Efficacy of Therapeutic Plasma Exchange for Transplant-Associated Thrombotic Microangiopathy in a Real-World Large Cohort Study

Tacrolimus Plus High-Dose Dexamethasone Versus High-Dose Dexamethasone Alone As First-Line Treatment for Adult Immune Thrombocytopenia: The Phase 2, Open Label, Randomized Trial (TARGET 020)

Superiority of Leukemic Stem Cell-Based Minimal Residual Disease Assay to Traditional Multiparameter Flow Cytometry-Based Method for Relapse Prediction in AML Patients: A Prospective Study with Randomized Training and Validation Sets

Machine-Learning Based Early Warning System for Prediction for Disseminated Intravascular Coagulation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Multicenter Study

M1 and M2 Macrophages Play Different Roles in the Pathogenesis of Acute Graft-Versus-Host Disease Post-Allotransplant By Modulating Immune Microenvironment

Development and Validation of a Prognostic Model for Transplant-Associated Thrombotic Microangiopathy Following Allogeneic Hematopoietic Stem Cell Transplantation

Haploidentical Hematopoietic Stem Cell Transplantation May Improve Prognosis in Non-Infant Children with t(v;11q23)/MLL-Rearranged B-Acute Lymphoblastic Leukemia

Regulation of the Elevated T Cell Glycolysis May Alleviate Acute Graft-Versus-Host Disease Post-Allotransplant

Autophagy in Endothelial Cells Regulates Their Hematopoiesis Supporting Ability

Rituximab for Desensitization during HLA-Mismatched Stem Cell Transplantation in Patients with a Positive Donor Specific Anti-HLA Antibody: A Prospective Study

Comparable Outcomes after Hematopoietic Stem Cell Transplantation from Mother Donors and Matched Unrelated Donors in Patients with Hematopoietic Malignancies

Positive Stool Cultures Could Predict the Clinical Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation

Hepatitis E Virus Infection after Haploidentical Hematopoietic Stem Cell Transplantation:Incidence and Clinical Course

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only